Mutation of recA gene of Vibrio cholerae: Towards the development of attenuated vibrio cholerae vaccine strains
Despite over hundred years of study, the intestinal pathogen Vibrio cholerae still causes epidemic outbreaks in areas of the world. The endemic areas include India, Asia, Africa, the Mediterranean, and more recently, South and Central America, Mexico and the United States (Faruque et a/, 1998). T...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2004
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/44196/1/LI...Goh%20Lai%20Kuan...2004...-24%20pages.pdf http://eprints.usm.my/44196/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Despite over hundred years of study, the intestinal pathogen Vibrio cholerae still
causes epidemic outbreaks in areas of the world. The endemic areas include India, Asia,
Africa, the Mediterranean, and more recently, South and Central America, Mexico and the
United States (Faruque et a/, 1998). This Gram-negative bacterium cplonizes the human
intestine and causes potentially fatal diarrhoeal disease- the Cholera.
A number of genes associated with the virulence of Vibrios had so far been identified
by researchers of cholera. These genes are gaining popularity among researchers especially in
the manipulation of them towards the production of an effective cholera vaccine.
In this research, however, the recA gene was the center of interest. It was reported by
Ghosh et al (1985) that the Vibrio cholerae have a RecA system that is analogous to the
Escherichia coli RecA system. The RecA protein is the central enzyme for homologous
recombination, DNA strand exchange, and DNA repair mechanism (Kuzminov, 1999). In the
development of live attenuated, oral cholera vaccine, the mutation of recA gene was strongly
recommended by some researchers to render the vaccine strains recombination deficient
(Goldberg and Mekalanos, 1986; Taylor et al, 1994; Kenner et al, 1995; Kaper et al, 1994;
Boyd and Waldor, 1999). Hence, the general approach of study is to mutate the recA gene in
existing vaccine strain (VCUSM-2) to stabilize and prevent the strain from further acquiring
the undesirable gene when released to the environment.
The study began with a deletional mutation in the 1.2kb Vibrio cholerae recA gene
previously cloned onto the vector, pTOP02.1. The EstEll was recognized as the unique
restriction enzyme site which existed twice in the middle of Vibrio cholerae recA gene at the
location of 71 Obp and 782bp. Upon restriction with EstEll, a small fragment of gene with the
Isize of 72bp was deleted. The sticky overhang was polished and this was followed by a selfblunt
end ligation of the linearized plasmid. The deletional mutation of recA gene produced a
+ 1 frameshift mutation starting from the ligation junction to the down stream of recA gene.
As a result a stop codon was introduced at 748bp of the gene, and hence results in a truncated
recA gene product.
The successfully mutated Vibrio cholerae recA gene was then subcloned onto the
pBluescriptiiSK before it was transferred onto the pCVD442, a conjugatable suicide plasmid
for conjugation with the cholera vaccine strain, VCUSM-2. |
|---|